Member Info for _Mr_Big

Is there more info about the AZN fundraising? Thank you.

No joy from the oompa loompa tonight then?

NOZ - probably.

Nolu - I'd expect SNG to be first used on folk who are already sick and getting the worst of it and clutching straws. Then, perhaps, roll out to milder cases of covid. Plus interferon has been safely used for years - we are mainly changing the delivery method?
Vaccines will be going into healthy people, kids, etc.

Had a very quick chat with a local lassie who used to work in immunology and has also done a stint of treating covid patients in the local hospital during the first outbreak. I am trying my best not to talk to people about covid these days, because sng is the only thing I can think about, but she was keen to share some of her views on the second wave:
- Second wave expected soon and expected to be a lot worse than first.
- Vaccine nowhere near being ready to have any effect on second wave.
- "Southampton" are developing a very promising treatment, but it is still in very early stages of development and no way it will be ready for the second wave.

Unfortunately, she had to run before I could follow that up with questions about SNG, but it looks like the SNG word is getting around. A bit surprised that she thought it was "early stages" when we have thousands of doses being made every month. Also referred to us as "Southampton" as opposed to "SNG", "Synairgen", "a company" etc.

Nothing new, that hasn't been posted here before, and this is just one (well-informed) person's opinion, but it's good to see that SNG came up without me even asking about it. Most other (non medical professionals) people I spoke to were not aware of SNG001 at all.

I don't really do twatter, but it's interesting to see what sort of sh.te floats up to the surface sometimes.
This bloke's previous post was that he's out of control and is going to shoot up a school...
Must be genuine. I believe him.

Cosh - I am with you on this one. Media coverage so far was limited worldwide and almost non existent in the UK (as you might have noticed, I am particularly bitter about this). Vaccines, on the other hand, seem to be everywhere. Hence my rather dark thoughts that we'll be quietly snapped up by a pharma at a fraction of what we could have sold for, with pharma pocketing most of the profits. Still higher than current SP of course.

Got some coverage in the latest New Scientist. Just a sentence mentioning us and stating that results were great, but it was a tiny preliminary trial.
I think we deserve more, but any publicity is good.

RM is at risk then?

Mani - I hope they are!
I expected quite a bit more action over the last two weeks.

Well, I've decided myself to hold for at least 2 weeks, so a checkpoint is now due.
Positives:
- SP held and new II on board. Very strong response so far;
- Worldwide media attention - we must have hit every major news channel all over the world except China, Russia, North Korea and UK.
- Further confirmations suggesting interferon is the way to beat covid. And we have the best product.

The disappointing bits were:
- Minimal coverage in the UK;
- No further trials, approvals, proposed deals so far
- We could have had more IIs buying and less selling.

Overall, I think that my rather naive thoughts that the world actually cares about stopping covid have been brought to as halt. Nothing stopping us from already running a bigger trial int he USA, but obviously that hasn't happened. Nothing stopping UK gov supporting us - hasn't happened either. We are sitting on thousands of doses of the likely covid cure and the world has wasted two weeks and let people die by not distributing them.

I have become quite pessimistic about our future - I now think we are heading for a discount buyout (perhaps, 3-4 bags from current sp) in the next 6 months. Not quite the sensational bidding war and multiple licencing deals that I was hoping for (for the sake of my own pocket and the lives of people suffering from covid).

Only one way to find out how this ends.

feck.

Put it on a horse. Choose the horse by its name.

Howdy folks.

Been away from the screens since Friday morning - have I missed anything important?

Hope you all had a good weekend.

Trump wouldn't want to be out of this one when the yanks wake up and start posting Code 1s!

The companies have nothing in common apart from being in the same sector, really. Might as well be comparing SNG to RBS with same success. Different size, different scope, different mission, different stage in the lifecycle, different product.

Genuine answer:
GSK mcap: £77bn
SNG mcap: £296m

"Bleech" and "Trumpjuice" also good options.

Yep. took me 15 minutes to realise why SP's not moving.

Fish fingers!